This report contains market size and forecasts of Acne Vulgaris Treatment in Global, including the following market information:
Global Acne Vulgaris Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Acne Vulgaris Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Acne Vulgaris Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acne Vulgaris Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Acne Vulgaris Treatment Market Segment Percentages, By Type, 2020 (%)
CB-0601
CJM-112
CLS-007
Dapsone
DFD-10
DLX-2323
Others
China Acne Vulgaris Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Acne Vulgaris Treatment Market Segment Percentages, By Application, 2020 (%)
Clinic
Hospital
Others
Global Acne Vulgaris Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Acne Vulgaris Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Acne Vulgaris Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Acne Vulgaris Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Common Pharma Inc
Cutanea Life Sciences Inc
Dermira Inc
ELORAC Inc
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline Plc
Helix BioMedix Inc
Hovione FarmaCiencia SA
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
Novabiotics Ltd
Novan Inc
Novartis AG
Paratek Pharmaceuticals Inc
Pfizer Inc
Phosphagenics Ltd
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Acne Vulgaris Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acne Vulgaris Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acne Vulgaris Treatment Overall Market Size
2.1 Global Acne Vulgaris Treatment Market Size: 2021 VS 2027
2.2 Global Acne Vulgaris Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acne Vulgaris Treatment Players in Global Market
3.2 Top Global Acne Vulgaris Treatment Companies Ranked by Revenue
3.3 Global Acne Vulgaris Treatment Revenue by Companies
3.4 Top 3 and Top 5 Acne Vulgaris Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Acne Vulgaris Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acne Vulgaris Treatment Players in Global Market
3.6.1 List of Global Tier 1 Acne Vulgaris Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Acne Vulgaris Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Acne Vulgaris Treatment Market Size Markets, 2021 & 2027
4.1.2 CB-0601
4.1.3 CJM-112
4.1.4 CLS-007
4.1.5 Dapsone
4.1.6 DFD-10
4.1.7 DLX-2323
4.1.8 Others
4.2 By Type - Global Acne Vulgaris Treatment Revenue & Forecasts
4.2.1 By Type - Global Acne Vulgaris Treatment Revenue, 2016-2021
4.2.2 By Type - Global Acne Vulgaris Treatment Revenue, 2022-2027
4.2.3 By Type - Global Acne Vulgaris Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acne Vulgaris Treatment Market Size, 2021 & 2027
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Acne Vulgaris Treatment Revenue & Forecasts
5.2.1 By Application - Global Acne Vulgaris Treatment Revenue, 2016-2021
5.2.2 By Application - Global Acne Vulgaris Treatment Revenue, 2022-2027
5.2.3 By Application - Global Acne Vulgaris Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Acne Vulgaris Treatment Market Size, 2021 & 2027
6.2 By Region - Global Acne Vulgaris Treatment Revenue & Forecasts
6.2.1 By Region - Global Acne Vulgaris Treatment Revenue, 2016-2021
6.2.2 By Region - Global Acne Vulgaris Treatment Revenue, 2022-2027
6.2.3 By Region - Global Acne Vulgaris Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Acne Vulgaris Treatment Revenue, 2016-2027
6.3.2 US Acne Vulgaris Treatment Market Size, 2016-2027
6.3.3 Canada Acne Vulgaris Treatment Market Size, 2016-2027
6.3.4 Mexico Acne Vulgaris Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Acne Vulgaris Treatment Revenue, 2016-2027
6.4.2 Germany Acne Vulgaris Treatment Market Size, 2016-2027
6.4.3 France Acne Vulgaris Treatment Market Size, 2016-2027
6.4.4 U.K. Acne Vulgaris Treatment Market Size, 2016-2027
6.4.5 Italy Acne Vulgaris Treatment Market Size, 2016-2027
6.4.6 Russia Acne Vulgaris Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Acne Vulgaris Treatment Market Size, 2016-2027
6.4.8 Benelux Acne Vulgaris Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Acne Vulgaris Treatment Revenue, 2016-2027
6.5.2 China Acne Vulgaris Treatment Market Size, 2016-2027
6.5.3 Japan Acne Vulgaris Treatment Market Size, 2016-2027
6.5.4 South Korea Acne Vulgaris Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Acne Vulgaris Treatment Market Size, 2016-2027
6.5.6 India Acne Vulgaris Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Acne Vulgaris Treatment Revenue, 2016-2027
6.6.2 Brazil Acne Vulgaris Treatment Market Size, 2016-2027
6.6.3 Argentina Acne Vulgaris Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acne Vulgaris Treatment Revenue, 2016-2027
6.7.2 Turkey Acne Vulgaris Treatment Market Size, 2016-2027
6.7.3 Israel Acne Vulgaris Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Acne Vulgaris Treatment Market Size, 2016-2027
6.7.5 UAE Acne Vulgaris Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Common Pharma Inc
7.1.1 Common Pharma Inc Corporate Summary
7.1.2 Common Pharma Inc Business Overview
7.1.3 Common Pharma Inc Acne Vulgaris Treatment Major Product Offerings
7.1.4 Common Pharma Inc Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.1.5 Common Pharma Inc Key News
7.2 Cutanea Life Sciences Inc
7.2.1 Cutanea Life Sciences Inc Corporate Summary
7.2.2 Cutanea Life Sciences Inc Business Overview
7.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Major Product Offerings
7.2.4 Cutanea Life Sciences Inc Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.2.5 Cutanea Life Sciences Inc Key News
7.3 Dermira Inc
7.3.1 Dermira Inc Corporate Summary
7.3.2 Dermira Inc Business Overview
7.3.3 Dermira Inc Acne Vulgaris Treatment Major Product Offerings
7.3.4 Dermira Inc Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.3.5 Dermira Inc Key News
7.4 ELORAC Inc
7.4.1 ELORAC Inc Corporate Summary
7.4.2 ELORAC Inc Business Overview
7.4.3 ELORAC Inc Acne Vulgaris Treatment Major Product Offerings
7.4.4 ELORAC Inc Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.4.5 ELORAC Inc Key News
7.5 Ensol Biosciences Inc
7.5.1 Ensol Biosciences Inc Corporate Summary
7.5.2 Ensol Biosciences Inc Business Overview
7.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Major Product Offerings
7.5.4 Ensol Biosciences Inc Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.5.5 Ensol Biosciences Inc Key News
7.6 Foamix Pharmaceuticals Ltd
7.6.1 Foamix Pharmaceuticals Ltd Corporate Summary
7.6.2 Foamix Pharmaceuticals Ltd Business Overview
7.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Major Product Offerings
7.6.4 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.6.5 Foamix Pharmaceuticals Ltd Key News
7.7 Galderma SA
7.7.1 Galderma SA Corporate Summary
7.7.2 Galderma SA Business Overview
7.7.3 Galderma SA Acne Vulgaris Treatment Major Product Offerings
7.4.4 Galderma SA Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.7.5 Galderma SA Key News
7.8 GlaxoSmithKline Plc
7.8.1 GlaxoSmithKline Plc Corporate Summary
7.8.2 GlaxoSmithKline Plc Business Overview
7.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Major Product Offerings
7.8.4 GlaxoSmithKline Plc Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.8.5 GlaxoSmithKline Plc Key News
7.9 Helix BioMedix Inc
7.9.1 Helix BioMedix Inc Corporate Summary
7.9.2 Helix BioMedix Inc Business Overview
7.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Major Product Offerings
7.9.4 Helix BioMedix Inc Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.9.5 Helix BioMedix Inc Key News
7.10 Hovione FarmaCiencia SA
7.10.1 Hovione FarmaCiencia SA Corporate Summary
7.10.2 Hovione FarmaCiencia SA Business Overview
7.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Major Product Offerings
7.10.4 Hovione FarmaCiencia SA Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.10.5 Hovione FarmaCiencia SA Key News
7.11 Lee's Pharmaceutical Holdings Ltd
7.11.1 Lee's Pharmaceutical Holdings Ltd Corporate Summary
7.11.2 Lee's Pharmaceutical Holdings Ltd Business Overview
7.11.3 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Major Product Offerings
7.11.4 Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.11.5 Lee's Pharmaceutical Holdings Ltd Key News
7.12 LEO Pharma A/S
7.12.1 LEO Pharma A/S Corporate Summary
7.12.2 LEO Pharma A/S Business Overview
7.12.3 LEO Pharma A/S Acne Vulgaris Treatment Major Product Offerings
7.12.4 LEO Pharma A/S Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.12.5 LEO Pharma A/S Key News
7.13 Novabiotics Ltd
7.13.1 Novabiotics Ltd Corporate Summary
7.13.2 Novabiotics Ltd Business Overview
7.13.3 Novabiotics Ltd Acne Vulgaris Treatment Major Product Offerings
7.13.4 Novabiotics Ltd Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.13.5 Novabiotics Ltd Key News
7.14 Novan Inc
7.14.1 Novan Inc Corporate Summary
7.14.2 Novan Inc Business Overview
7.14.3 Novan Inc Acne Vulgaris Treatment Major Product Offerings
7.14.4 Novan Inc Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.14.5 Novan Inc Key News
7.15 Novartis AG
7.15.1 Novartis AG Corporate Summary
7.15.2 Novartis AG Business Overview
7.15.3 Novartis AG Acne Vulgaris Treatment Major Product Offerings
7.15.4 Novartis AG Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.15.5 Novartis AG Key News
7.16 Paratek Pharmaceuticals Inc
7.16.1 Paratek Pharmaceuticals Inc Corporate Summary
7.16.2 Paratek Pharmaceuticals Inc Business Overview
7.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Major Product Offerings
7.16.4 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.16.5 Paratek Pharmaceuticals Inc Key News
7.17 Pfizer Inc
7.17.1 Pfizer Inc Corporate Summary
7.17.2 Pfizer Inc Business Overview
7.17.3 Pfizer Inc Acne Vulgaris Treatment Major Product Offerings
7.17.4 Pfizer Inc Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.17.5 Pfizer Inc Key News
7.18 Phosphagenics Ltd
7.18.1 Phosphagenics Ltd Corporate Summary
7.18.2 Phosphagenics Ltd Business Overview
7.18.3 Phosphagenics Ltd Acne Vulgaris Treatment Major Product Offerings
7.18.4 Phosphagenics Ltd Acne Vulgaris Treatment Revenue in Global (2016-2021)
7.18.5 Phosphagenics Ltd Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Acne Vulgaris Treatment Market Opportunities & Trends in Global Market
Table 2. Acne Vulgaris Treatment Market Drivers in Global Market
Table 3. Acne Vulgaris Treatment Market Restraints in Global Market
Table 4. Key Players of Acne Vulgaris Treatment in Global Market
Table 5. Top Acne Vulgaris Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Acne Vulgaris Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Acne Vulgaris Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Acne Vulgaris Treatment Product Type
Table 9. List of Global Tier 1 Acne Vulgaris Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acne Vulgaris Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type
Common Pharma Inc
Cutanea Life Sciences Inc
Dermira Inc
ELORAC Inc
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline Plc
Helix BioMedix Inc
Hovione FarmaCiencia SA
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
Novabiotics Ltd
Novan Inc
Novartis AG
Paratek Pharmaceuticals Inc
Pfizer Inc
Phosphagenics Ltd